Clinical Trials Logo
  1. Home
  2. Ocular Inflammation
  3. NCT00789971

Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification

Ocular Inflammation Clinical Trial

Official title:
A Comparison of a Single Orbital Floor Injection of Triamcinolone Versus Conventional Steroid and Antibiotic Drops Used Post Operatively in Uneventful Phacoemulsification Surgery

Clinical Trial Summary

Cataract extraction is one of the most common operative procedures performed throughout the world. Conventionally, patients are discharged with postoperative drops of steroids and antibiotics or a combination of both. These drops are to be administered for 2-6 weeks depending on individual eye unit protocol. Many patients find the postoperative drops arduous and non-compliance can cause prolonged inflammation and discomfort. Patients with cognitive, physical and visual impairments require assistance from family or community nurses to administer drops. A single perioperative injection of Triamcinolone has been shown to be an effective replacement for drops postoperatively in two previous studies 1, 2.

Aims & objectives

The aim of this study is to see if a single orbital floor injection of Triamcinolone is equivalent to conventional steroid and antibiotic drops used post operatively in uneventful phacoemulsification surgery in treating postoperative inflammation.

Clinical Trial Description

This is a prospective randomized control trial of 80 patients undergoing routine phacoemulsification cataract extraction. The patients were randomly assigned to receive the triamcinolone injection or post operative topical treatment of G Maxitriol QDS 1/52 tapering over one month. Forty mg of triamcinolone was injected inferior temporally immediately post operatively prior to undraping the patient in theatre in those randomized to this group. The patients were reviewed at week one and at one month. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00789971
Study type Interventional
Source Sligo General Hospital
Contact
Status Completed
Phase N/A
Start date March 2007
Completion date April 2008
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05618730 - Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B Phase 1
Not yet recruiting NCT05248139 - Safety and Effectiveness of Drop-free Small Incision Cataract Surgery N/A
Terminated NCT01214174 - Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients Phase 2
Completed NCT03332342 - Closed Eye Neutrophils in Dry Eye Disease N/A
Completed NCT02128113 - RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD Phase 2
Completed NCT01808547 - Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects Phase 3
Completed NCT04374656 - Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic
Recruiting NCT05668455 - Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses) Phase 3
Completed NCT00645671 - Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery Phase 3
Completed NCT02786901 - LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery Phase 3
Completed NCT00699153 - Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery Phase 3
Terminated NCT03596723 - KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children Phase 3
Completed NCT01576952 - Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects Phase 3
Withdrawn NCT03408015 - Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Disease Phase 4
Completed NCT03580473 - Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification Phase 2
Completed NCT04812951 - Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery Early Phase 1
Completed NCT03302273 - Corneal Epithelial Stem Cells and Dry Eye Disease N/A
Completed NCT04690829 - Biomarkers in Ocular Inflammation and Uveitis
Withdrawn NCT01721694 - Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection Phase 3
Completed NCT03521791 - Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. Phase 4